tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Liav Abraham, 55 are a BUY (77.46%), 14 are a HOLD (19.72%), 2 are a SELL (2.82%).
Analyst Liav Abraham, currently employed at CREDIT SUISSE, carries an average stock price target met ratio of 55.28% that have a potential upside of 23.25% achieved within 300 days. Previously, Liav Abraham worked at CITI.
Liav Abraham’s has documented 150 price targets and ratings displayed on 12 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on ELAN, Elanco Animal Health at 05-Aug-2021.
Analyst best performing recommendations are on INSM (INSMED).
The best stock recommendation documented was for TEVA (TEVA PHARMA INDUSTRIES LTD ADR) at 5/1/2018. The price target of $24 was fulfilled within 42 days with a profit of $5.29 (28.27%) receiving and performance score of 6.73.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$193
$-0.02 (-0.01%)
4 years 6 months 27 days ago
(21-Apr-2020)
2/7 (28.57%)
$8.96 (4.87%)
35
Buy
$203
4 years 8 months 30 days ago
(18-Feb-2020)
1/2 (50%)
$20.22 (11.61%)
95
Hold
$203
$9.98 (5.17%)
$178
4 years 9 months 7 days ago
(10-Feb-2020)
6/19 (31.58%)
$3.35 (1.68%)
69
Buy
$247
5 years 3 months 10 days ago
(07-Aug-2019)
0/4 (0%)
$88.31 (55.65%)
Hold
$157
$-36.02 (-18.66%)
$161
5 years 3 months 10 days ago
(07-Aug-2019)
10/10 (100%)
$-1.84 (-1.16%)
200
What Year was the first public recommendation made by Liav Abraham?
